Amanta Healthcare Ltd (MAINBOARD)

IPO Details

Key Performance Indicator (KPI)

Company Financial ( In ₹Crore)

Peer Comparison (Valuation)

About Compay

• Incorporation: December 1994
• Industry: Pharmaceuticals & Medical Devices
• Specialization: Development, manufacturing, and marketing of sterile liquid products, primarily parenteral products.
• Key Technologies:
  • Aseptic Blow-Fill-Seal (ABFS)
  • Injection Stretch Blow Moulding (ISBM)

Product Portfolio

• Pharmaceutical Products:
  • Fluid therapy formulations (IV fluids, diluents)
  • Ophthalmic solutions
  • Respiratory care products
• Medical Devices:
  • Irrigation solutions
  • First-aid products
  • Eye lubricants

Business Operations :

• Operates through three main business units:
  1. National Sales
  2. International Sales
  3. Product Partnering (with Indian and foreign pharmaceutical companies)
• Manufactures 45+ generic products, marketed under its own brands in India through a network of 189 distributors and stockists.

Global Presence :

• Products registered in 19 countries.
• Exports branded products to 19 countries, including Africa, Latin America, and the UK.
• Fully compliant with multiple international regulations.

Strength

Rising Healthcare Awareness: Growing access to healthcare, medicines, and health insurance in India supports strong demand for pharmaceuticals.

Government Support: Favorable policies like the PLI scheme, tax incentives, and infrastructure subsidies boost industry growth.

Skilled Talent Pool: benefits from a large base of scientists, researchers, and engineers, strengthening its pharmaceutical capabilities.

Weakness

Single Manufacturing Facility Risk: Dependence on one facility in Gujarat exposes operations to disruptions from power shortages, accidents, natural disasters, or other unforeseen events.

Production & Quality Risks: Delays, quality issues, or failure to deliver products on time may lead to order cancellations and loss of clients or distributors.